Ftse Mib
34.127,62
-0,72%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
98.290,07
0,19%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Daxor Corporation (DXR) Daxor Corporation (DXR) Notizie

Daxor Corporation

DXR
7,765
0,215 (2,85%)
04 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/12/202414:00GLOBEDaxor Expands Its BVA-100™ Blood Volume Diagnostic to Two..
11/12/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202422:00EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
09/10/202414:00GLOBEDAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED..
08/10/202414:00GLOBEDaxor Corporation to Participate in a Fireside Chat at the..
27/9/202423:00GLOBEDaxor Corporation Streamlines Regulatory Strategy for..
19/9/202414:00GLOBEDaxor Corporation to Exhibit at the Heart Failure Society of..
12/9/202414:00GLOBENewly Published Review Highlights the Pivotal Role of..
05/9/202414:00GLOBEDaxor Corporation Receives $300K Matching Fund Award From..
04/9/202414:30GLOBELeading Central Florida Hospital Implements Daxor’s BVA-100™..
03/9/202422:05GLOBEDaxor Corporation CEO and President Michael Feldschuh..
03/9/202418:15GLOBEDaxor Corporation to Present at the H.C. Wainwright 26th..
29/8/202423:16EDGAR2Form N-CSRS - Certified Shareholder Report, Semi-Annual
29/8/202414:00GLOBEDaxor Corporation Announces Launch of BVA Program at..
23/8/202422:52EDGAR2Form 40-17G - Fidelity Bond [Rule 17G-1(g)]
16/8/202423:23EDGAR2Form N-2 - Registration statement for closed-end investment..
06/8/202414:00GLOBEDaxor Corporation Awarded $1.9M Contract by The U.S. Air..
05/8/202414:00GLOBEDaxor Expands To Three New Facilities As Blood Volume..
24/7/202414:00GLOBEDaxor Corporation Awarded New U.S. Defense Health Agency..
18/7/202420:46EDGAR2Form 8-K - Current report
18/7/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202414:00GLOBEDaxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands..
18/6/202414:00GLOBEDaxor Corporation to Showcase the Benefits of BVA-100™..
05/6/202422:10EDGAR2Form 8-K - Current report
05/6/202414:00GLOBEDaxor Corporation Appoints John L. Jefferies, M.D. as Chief..
16/4/202414:00GLOBENew Studies Prove the Clinical Benefits of Daxor’s Blood..
15/4/202414:00GLOBEDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR..
10/4/202414:00GLOBEDaxor Corporation Announces New Hospital Account at Leading..
01/4/202414:00GLOBEDaxor Corporation to Exhibit at the American College of..
25/3/202413:00GLOBEDaxor Corporation Acquires Volumex® and Megatope® From Its..
22/3/202413:00GLOBEDaxor Corporation to Hold Investor Call Discussing Fiscal..
18/3/202419:18GLOBEDaxor Corporation Reports Increase in NAV to $7.08 Per Share..
11/3/202413:00GLOBEDaxor Announces Sales to Three New Hospitals Furthering..
08/3/202419:49EDGAR2Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of..
08/3/202414:00GLOBEMulti-Center Study Presented by Duke at Heart Failure..
06/3/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:28EDGAR2Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of..
29/2/202422:15EDGAR2Form NT-NCSR - Notice under Exchange Act Rule 12b-25 of..
26/2/202414:00GLOBEDaxor Corporation to Exhibit at the Technology and Heart..
12/2/202414:00GLOBEDaxor Corporation Starts 2024 with Ongoing Growth in New..
07/2/202414:00GLOBEDaxor Corporation Closes Q4 2023 with Growth in New Sales to..
29/1/202414:00GLOBEDaxor Corporation to Exhibit at the Society of Nuclear..
16/1/202414:00GLOBEDaxor Corporation to Exhibit at the Society for Critical..
09/1/202414:00GLOBEDAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME..
Apertura: 7,70 Min: 7,70 Max: 7,765
Chiusura: 7,55

La tua Cronologia

NASDAQ
DXR
Daxor
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network